Biocon gets 6 observations from USFDA for Malaysia facility

As per the US health regulator, observations are made in Form 483 when investigators feel that conditions or practices in the facility are such that products may become adulterated or render injuries to health.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news